IL10RB expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.094000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.801200E-01
Normal-vs-Stage2
8.478400E-01
Normal-vs-Stage3
1.166200E-01
Normal-vs-Stage4
9.502800E-01
Stage1-vs-Stage2
3.195200E-01
Stage1-vs-Stage3
4.822600E-01
Stage1-vs-Stage4
2.190800E-01
Stage2-vs-Stage3
1.345160E-01
Stage2-vs-Stage4
5.421000E-01
Stage3-vs-Stage4
6.974400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.431000E-01
Normal-vs-AfricanAmerican
8.213600E-01
Normal-vs-Asian
7.135800E-01
Caucasian-vs-AfricanAmerican
7.269800E-01
Caucasian-vs-Asian
8.806100E-02
AfricanAmerican-vs-Asian
4.915800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.363200E-01
Normal-vs-Female
4.743200E-01
Male-vs-Female
2.060400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.312600E-01
Normal-vs-Age(41-60Yrs)
8.741200E-01
Normal-vs-Age(61-80Yrs)
5.572400E-01
Normal-vs-Age(81-100Yrs)
3.463200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.158400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.632000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.389200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.864800E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.034300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.090200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.905000E-01
Normal-vs-Daily Drinker
3.688000E-01
Normal-vs-Weekly Drinker
4.850000E-01
Normal-vs-Occasional Drinker
9.319600E-01
Normal-vs-Social Drinker
9.144800E-01
Non Drinker-vs-Daily Drinker
5.124600E-01
Non Drinker-vs-Weekly Drinker
8.219400E-01
Non Drinker-vs-Occasional Drinker
3.794200E-01
Non Drinker-vs-Social Drinker
3.797000E-01
Daily Drinker-vs-Weekly Drinker
7.317400E-01
Daily Drinker-vs-Occasional Drinker
1.519370E-01
Daily Drinker-vs-Social Drinker
1.395750E-01
Weekly Drinker-vs-Occasional Drinker
3.349600E-01
Weekly Drinker-vs-Social Drinker
3.030200E-01
Occasional Drinker-vs-Social Drinker
9.966800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.338200E-01
Normal-vs-Grade 2
5.866000E-02
Normal-vs-Grade 3
1.835510E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.580100E-03
Grade 1-vs-Grade 3
7.016800E-04
Grade 1-vs-Grade 4
2.338200E-01
Grade 2-vs-Grade 3
5.088400E-01
Grade 2-vs-Grade 4
5.866000E-02
Grade 3-vs-Grade 4
1.835510E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.455000E-01
Normal-vs-NonDiabetic
6.439200E-01
Diabetic-vs-NonDiabetic
3.383200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.588000E-01
Normal-vs-NoPancreatitis
5.635800E-01
Pancreatitis-vs-NoPancreatitis
1.399610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.661600E-01
Normal-vs-N1
8.248400E-01
N0-vs-N1
1.224210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.872200E-01
Normal-vs-TP53-NonMutant
5.896200E-01
TP53-Mutant-vs-TP53-NonMutant
2.550400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
